ImmunityBio, Inc.
DE ˙ DB ˙ US45256X1037
6,33 € ↑0,20 (3,26%)
2026-06-04
DEL PRIS
SecurityDE:26CA / ImmunityBio, Inc.
InstitutionProShare Advisors LLC
Latest Disclosed Ownership88,769 shares
Latest Disclosed Value $ 680,858
ProShare Advisors LLC reports 8.90% decrease in ownership of 26CA / ImmunityBio, Inc.

On April 24, 2026 - ProShare Advisors LLC filed a 13F-HR form disclosing ownership of 88,769 shares of ImmunityBio, Inc. (DE:26CA) valued at $582,325 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 97,440 shares of ImmunityBio, Inc.. This represents a change in shares of -8.90% during the quarter. The current value of the position is $561,908 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F IMMUNITYBIO COM 45256X103 88,769 -8,671 -8.90 681 254.17 0.0010
2026-02-06 2025-12-31 13F IMMUNITYBIO COM 45256X103 97,440 24,434 33.47 193 7.26 0.0003
2025-11-06 2025-09-30 13F IMMUNITYBIO COM 45256X103 73,006 -7,122 -8.89 180 -15.17 0.0004
2025-08-07 2025-06-30 13F IMMUNITYBIO COM 45256X103 80,128 14,105 21.36 212 6.57 0.0004
2025-05-08 2025-03-31 13F IMMUNITYBIO COM 45256X103 66,023 -7,750 -10.51 199 5.32 0.0004
2025-02-14 2024-12-31 13F IMMUNITYBIO COM 45256X103 73,773 5,261 7.68 189 -25.98 0.0004
2024-11-14 2024-09-30 13F IMMUNITYBIO COM 45256X103 68,512 8,059 13.33 255 -33.51 0.0006
2024-08-13 2024-06-30 13F IMMUNITYBIO COM 45256X103 60,453 -10,160 -14.39 382 0.79 0.0010
2024-05-08 2024-03-31 13F IMMUNITYBIO COM 45256X103 70,613 6,004 9.29 379 16.98 0.0010
2024-02-14 2023-12-31 13F IMMUNITYBIO COM 45256X103 64,609 19,981 44.77 324 332.00 0.0010
2023-11-13 2023-09-30 13F IMMUNITYBIO COM 45256X103 44,628 2,080 4.89 75 -36.44 0.0002
2023-08-10 2023-06-30 13F IMMUNITYBIO COM 45256X103 42,548 4,185 10.91 118 71.01 0.0003
2023-05-26 2023-03-31 13F/A-1 IMMUNITYBIO COM 45256X103 38,363 -5,278 -12.09 70 -68.78 0.0002
2023-05-12 2023-03-31 13F IMMUNITYBIO COM 45256X103 38,363 -5,278 70 0.0002
2023-02-02 2022-12-31 13F IMMUNITYBIO COM 45256X103 43,641 944 2.21 221 4.25 0.0008
2022-11-07 2022-09-30 13F IMMUNITYBIO COM 45256X103 42,697 2,510 6.25 212 41.33 0.0008
2022-08-01 2022-06-30 13F IMMUNITYBIO COM 45256X103 40,187 -14,004 -25.84 150 -50.66 0.0005
2022-05-10 2022-03-31 13F IMMUNITYBIO COM 45256X103 54,191 -16,719 -23.58 304 -29.47 0.0007
2022-02-08 2021-12-31 13F IMMUNITYBIO COM 45256X103 70,910 -21,404 -23.19 431 -52.06 0.0008
2021-11-12 2021-09-30 13F IMMUNITYBIO COM 45256X103 92,314 5,983 6.93 899 -27.09 0.0025
2021-08-13 2021-06-30 13F IMMUNITYBIO COM 45256X103 86,331 62,807 266.99 1,233 120.97 0.0036
2021-05-14 2021-03-31 13F IMMUNITYBIO COM 45256X103 23,524 -213 -0.90 558 76.58 0.0018
2021-02-09 2020-12-31 13F NANTKWEST COM 63016Q102 23,737 23,737 316 0.0012
2019-02-14 2018-12-31 13F NANTKWEST COM 63016Q102 0 -35,750 -100.00 0 -100.00
2018-11-14 2018-09-30 13F NANTKWEST COM 63016Q102 35,750 -730 -2.00 132 17.86 0.0009
2018-08-13 2018-06-30 13F NANTKWEST COM 63016Q102 36,480 -4,032 -9.95 112 -29.11 0.0008
2018-05-14 2018-03-31 13F NANTKWEST COM 63016Q102 40,512 -6,677 -14.15 158 -25.47 0.0010
2018-02-14 2017-12-31 13F NANTKWEST COM 63016Q102 47,189 345 0.74 212 -17.51 0.0015
2017-11-13 2017-09-30 13F NANTKWEST COM 63016Q102 46,844 1,975 4.40 257 -24.63 0.0024
2017-08-11 2017-06-30 13F NANTKWEST COM 63016Q102 44,869 -1,016 -2.21 341 109.20 0.0034
2017-05-12 2017-03-31 13F/A-2 NANTKWEST COM 63016Q102 45,885 -11,214 -19.64 163 -50.15 0.0017
2017-05-08 2017-03-31 13F/A-1 NANTKWEST COM 63016Q102 45,885 0 163 0.0017
2017-04-25 2017-03-31 13F NANTKWEST COM 63016Q102 45,885 163
2017-02-13 2016-12-31 13F NANTKWEST COM 63016Q102 57,099 3,555 6.64 327 -21.58 0.0036
2016-11-10 2016-09-30 13F NANTKWEST COM 63016Q102 53,544 -9,519 -15.09 417 6.38 0.0058
2016-08-12 2016-06-30 13F NANTKWEST COM 63016Q102 63,063 2,137 3.51 392 -21.76 0.0050
2016-05-06 2016-03-31 13F NANTKWEST COM 63016Q102 60,926 -5,356 -8.08 501 -56.40 0.0069
2016-02-05 2015-12-31 13F NANTKWEST COM 63016Q102 66,282 66,282 1,149 0.0139
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.